Lianhe Chemical Technology Co., Ltd.

SZSE:002250.SZ

7.68 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2023202220212020201920182017201620152014201320122011201020092008200720062005
Revenue 6,377.6137,865.4666,586.7814,781.7994,283.7844,114.1284,107.3893,099.314,007.7873,990.2663,368.3512,955.3622,568.0451,973.4491,340.5931,084.938986.979908.891756.421
Cost of Revenue 5,291.0945,808.8994,814.3193,056.1692,609.9392,977.1472,822.3652,064.5772,515.1582,648.1372,261.5722,023.2221,872.2671,458.334939.983808.605777.022720.873621.771
Gross Profit 1,086.5192,056.5661,772.4621,725.631,673.8461,136.981,285.0241,034.7331,492.6291,342.1291,106.779932.14695.778515.115400.61276.333209.958188.018134.65
Gross Profit Ratio 0.170.2610.2690.3610.3910.2760.3130.3340.3720.3360.3290.3150.2710.2610.2990.2550.2130.2070.178
Reseach & Development Expenses 359.772394.714317.12262.761218.38176.392148.298129.993157.778134.292100.5194.76349.62428.31608.379000
General & Administrative Expenses 220.24202.256168.048197.596222.344190.44332.759218.304262.487225.418188.027175.352117.793107.44172.77176.82288.97571.57249.987
Selling & Marketing Expenses 32.74712.45214.70311.45965.71754.76744.91227.99138.31942.26142.5939.32242.42928.49442.60231.33923.88625.90824.084
SG&A 667.394214.707182.751209.055288.06245.207377.67246.295300.806267.679230.617214.673160.222135.934215.373108.162112.86297.4874.07
Other Expenses -76.511603.621634.121640.065575.719-41.085-15.77481.88713.1648.2165.5527.9769.2376.4325.68611.3070.53610.3940.705
Operating Expenses 1,103.6771,213.0421,133.9931,111.8811,082.16849.545979.913730.412743.653642.255543.637463.071341.457251.321218.763169.623114.946100.86975.284
Operating Income -17.1581,110.157608.105579.703613.677132.981271.611251.888736.121663.418526.276435.977342.404248.384168.69886.86780.78486.751.677
Operating Income Ratio -0.0030.1410.0920.1210.1430.0320.0660.0810.1840.1660.1560.1480.1330.1260.1260.080.0820.0950.068
Total Other Income Expenses Net -383.6-165.718-191.264-370.348-303.393-195.54-49.2745.95-12.873-43.403-35.261-28.269-8.283-15.69-14.895-8.767-13.767-3.319-7.205
Income Before Tax -400.758944.439416.841209.355310.28491.896255.837310.271736.103656.471527.881440.799346.038248.104166.95297.94281.24583.8352.162
Income Before Tax Ratio -0.0630.120.0630.0440.0720.0220.0620.10.1840.1650.1570.1490.1350.1260.1250.090.0820.0920.069
Income Tax Expense 27.468208.27393.85475.766114.30144.88148.32541.09491.52797.66674.06573.33848.66645.12637.322.74822.73222.4028.265
Net Income -465.244696.838315.405110.032195.98337.531201.341263.852638.072551.05449.559365.665294.335202.979129.5674.73658.2557.71738.74
Net Income Ratio -0.0730.0890.0480.0230.0460.0090.0490.0850.1590.1380.1330.1240.1150.1030.0970.0690.0590.0640.051
EPS -0.50.750.340.120.220.040.220.320.770.690.570.470.390.280.180.120.110.110.072
EPS Diluted -0.50.750.340.120.220.040.220.320.770.680.570.470.390.280.180.120.110.110.072
EBITDA 758.5931,704.461,179.1581,059.9781,060.154686.505719.818739.1671,037.063896.927721.55593.021433.516330.509234.344161.542125.18123.79875.869
EBITDA Ratio 0.1190.2170.1790.2220.2470.1670.1750.2380.2590.2250.2140.2010.1690.1670.1750.1490.1270.1360.1